Cargando…

Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure

BACKGROUND/AIMS: Emerging data links different aspects of lipid metabolism to liver regeneration. In patients with acute liver failure (ALF), low levels of lipids may correlate with disease severity. Thus, we determined whether there is an etiology-specific link between lipid levels in patients suff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manka, Paul, Olliges, Verena, Bechmann, Lars P., Schlattjan, Martin, Jochum, Christoph, Treckmann, Jürgen W., Saner, Fuat H., Gerken, Guido, Syn, Wing-Kin, Canbay, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099314/ https://www.ncbi.nlm.nih.gov/pubmed/25025159 http://dx.doi.org/10.1371/journal.pone.0102351

Ejemplares similares

Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure
por: Manka, Paul, et al.
Publicado: (2013)

Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure
por: Anastasiou, Olympia, et al.
Publicado: (2015)

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients
por: Kälsch, Julia, et al.
Publicado: (2011)

A Rare Case of Propofol-Induced Acute Liver Failure and Literature Review
por: Kneiseler, G., et al.
Publicado: (2010)

Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients
por: Buechter, Matthias, et al.
Publicado: (2018)

A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
por: Manka, Paul P., et al.
Publicado: (2021)

ERCP in critically ill patients is safe and does not increase mortality
por: Buechter, Matthias, et al.
Publicado: (2022)

Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage
por: Schreiter, Thomas, et al.
Publicado: (2016)

Glutathione-S-transferase subtypes α and π as a tool to predict and monitor graft failure or regeneration in a pilot study of living donor liver transplantation
por: Jochum, C, et al.
Publicado: (2011)

Aspergillus Tracheobronchitis Causing Subtotal Tracheal Stenosis in a Liver Transplant Recipient
por: Radunz, Sonia, et al.
Publicado: (2013)

NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease
por: Manka, Paul, et al.
Publicado: (2020)

Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis
por: Sydor, Svenja, et al.
Publicado: (2017)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Spleen Stiffness Differentiates Between Acute and Chronic Liver Damage and Predicts Hepatic Decompensation
por: Meister, Phil, et al.
Publicado: (2019)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

CTLA-4 Expression Plays a Role in PSC and PBC Progression
por: Meister, Phil, et al.
Publicado: (2020)

Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017)

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Mazzolini, Guillermo, et al.
Publicado: (2018)

When the heart kills the liver: acute liver failure in congestive heart failure
por: Saner, FH, et al.
Publicado: (2009)

Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
por: Kälsch, Julia, et al.
Publicado: (2015)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
por: Benkö, Tamás, et al.
Publicado: (2022)

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome
por: Tan, Susanne, et al.
Publicado: (2015)

A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver
por: Manka, Paul, et al.
Publicado: (2022)

From bedside to bench and back again—molecular mechanisms in acute liver failure
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management
por: Verbeek, Thomas A., et al.
Publicado: (2018)

Oxygen Persufflation in Liver Transplantation Results of a Randomized Controlled Trial
por: Gallinat, Anja, et al.
Publicado: (2019)

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD
por: Romano, John, et al.
Publicado: (2022)

Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience
por: Buechter, Matthias, et al.
Publicado: (2017)

Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
por: Mazzolini, Guillermo, et al.
Publicado: (2020)

Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis
por: Kreimeyer, Henriette, et al.
Publicado: (2023)

Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation
por: Buechter, Matthias, et al.
Publicado: (2017)

Lymph Node Staging in Perihilar Cholangiocarcinoma: The Key to the Big Picture
por: Rogacka, Nina A., et al.
Publicado: (2023)

Role of liver progenitors in acute liver injury
por: Best, Jan, et al.
Publicado: (2013)

Non-Invasive Separation of Alcoholic and Non-Alcoholic Liver Disease with Predictive Modeling
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
por: Nowak, Knut Michael, et al.
Publicado: (2016)

Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence
por: Saner, Fuat H., et al.
Publicado: (2023)

A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients
por: Saner, Fuat Hakan, et al.
Publicado: (2014)

Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics
por: Sydor, Svenja, et al.
Publicado: (2022)

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
por: Sydor, Svenja, et al.
Publicado: (2020)

All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells
por: Werner, Melanie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_37aoisif1f8cbl3qktgde5skd4